These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis. Khan AR; Farid TA; Pathan A; Tripathi A; Ghafghazi S; Wysoczynski M; Bolli R Circ Res; 2016 Mar; 118(6):984-93. PubMed ID: 26838794 [TBL] [Abstract][Full Text] [Related]
10. Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up. Hartikainen J; Hassinen I; Hedman A; Kivelä A; Saraste A; Knuuti J; Husso M; Mussalo H; Hedman M; Rissanen TT; Toivanen P; Heikura T; Witztum JL; Tsimikas S; Ylä-Herttuala S Eur Heart J; 2017 Sep; 38(33):2547-2555. PubMed ID: 28903476 [TBL] [Abstract][Full Text] [Related]
11. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial. Jolicœur EM; Banai S; Henry TD; Schwartz M; Doucet S; White CJ; Edelman E; Verheye S Trials; 2013 Feb; 14():46. PubMed ID: 23413981 [TBL] [Abstract][Full Text] [Related]
12. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW; JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607 [TBL] [Abstract][Full Text] [Related]
13. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. Kastrup J; Jørgensen E; Rück A; Tägil K; Glogar D; Ruzyllo W; Bøtker HE; Dudek D; Drvota V; Hesse B; Thuesen L; Blomberg P; Gyöngyösi M; Sylvén C; J Am Coll Cardiol; 2005 Apr; 45(7):982-8. PubMed ID: 15808751 [TBL] [Abstract][Full Text] [Related]
14. Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients. Reilly JP; Grise MA; Fortuin FD; Vale PR; Schaer GL; Lopez J; VAN Camp JR; Henry T; Richenbacher WE; Losordo DW; Schatz RA; Isner JM J Interv Cardiol; 2005 Feb; 18(1):27-31. PubMed ID: 15788051 [TBL] [Abstract][Full Text] [Related]
15. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study. Banai S; Ben Muvhar S; Parikh KH; Medina A; Sievert H; Seth A; Tsehori J; Paz Y; Sheinfeld A; Keren G J Am Coll Cardiol; 2007 May; 49(17):1783-9. PubMed ID: 17466229 [TBL] [Abstract][Full Text] [Related]
16. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958 [TBL] [Abstract][Full Text] [Related]